215380 — Woojung BIO Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Woojung BIO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	15,793	6,746	4,820	5,566	4,268
Net Total Accounts Receivable
Net Total Receivables	4,535	5,758	2,149	7,181	6,029
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,250	25,169	13,887	19,690	19,928
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35,650	57,281	63,715	56,130	51,581
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	69,816	100,136	94,994	98,333	94,699
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22,581	38,010	45,244	45,699	31,348
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	41,785	68,676	65,275	76,361	65,326
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	28,031	31,460	29,718	21,972	29,373
Total Liabilities & Shareholders' Equity	69,816	100,136	94,994	98,333	94,699
Total Common Shares Outstanding
Total Preferred Shares Outstanding